What is the initial treatment for an allergic reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Treatment for Allergic Reactions

Intramuscular epinephrine is the first-line treatment for anaphylaxis and severe allergic reactions and must be administered immediately—all other medications are adjunctive and should never replace or delay epinephrine. 1, 2, 3

Immediate Management Algorithm

Step 1: Recognize and Act

  • Administer epinephrine IM immediately into the anterolateral thigh at the first sign of anaphylaxis (systemic symptoms involving skin, respiratory, cardiovascular, or gastrointestinal systems) 1, 2
  • Do not delay epinephrine to give antihistamines—this is the most common error and significantly increases risk of progression to life-threatening reactions 1, 4
  • Call for help (911 in community settings, resuscitation team in hospitals) while administering epinephrine 1

Step 2: Epinephrine Dosing

Adults and children ≥30 kg:

  • 0.3-0.5 mg (0.3-0.5 mL of 1:1,000 solution) IM into anterolateral thigh 3

Children <30 kg:

  • 0.01 mg/kg (maximum 0.3 mg) IM into anterolateral thigh 2, 3

Repeat dosing:

  • Repeat every 5-15 minutes as needed if symptoms persist or progress 2, 3
  • Epinephrine remains first-line therapy over adjunctive treatments even when response is suboptimal 1

Step 3: Concurrent Supportive Measures

  • Position patient recumbent with lower extremities elevated (if tolerated) 1
  • Provide supplemental oxygen for any respiratory distress 2
  • Establish IV access and administer fluid boluses (10-20 mL/kg, repeated as needed) for hypotension or incomplete response to epinephrine 2

Step 4: Adjunctive Medications (After Epinephrine)

These are secondary treatments only and should never replace epinephrine 1:

H1 antihistamines:

  • Diphenhydramine 1-2 mg/kg (maximum 50 mg) IV or oral 4, 2
  • Continue every 6 hours for 2-3 days after discharge 4

H2 antihistamines:

  • Ranitidine 1-2 mg/kg (maximum 75-150 mg) or famotidine IV/oral 4
  • Combination of H1 and H2 antihistamines is more effective than either alone 4

Bronchodilators (if wheezing persists):

  • Albuterol 4-8 puffs (child) or 8 puffs (adult) via MDI, or nebulized every 20 minutes 2

Corticosteroids:

  • Prednisone 1 mg/kg (maximum 60-80 mg) oral or methylprednisolone IV 4
  • May help prevent biphasic reactions, though evidence is limited 4

Critical Pitfalls to Avoid

Common Error #1: Using Antihistamines Instead of Epinephrine

  • Using antihistamines as primary treatment is the most frequently reported reason for not using epinephrine and places patients at significantly increased risk 1, 4
  • Antihistamines have much slower onset of action than epinephrine and cannot prevent progression to life-threatening reactions 4

Common Error #2: Wrong Route or Site

  • Never inject into buttocks, digits, hands, or feet 3
  • Intramuscular injection into the anterolateral thigh provides optimal absorption 2, 3
  • Subcutaneous administration is acceptable but less preferred than IM 3

Common Error #3: Withholding Epinephrine Due to Cardiovascular Concerns

  • There are no absolute contraindications to epinephrine in anaphylaxis 1
  • The risk of death from anaphylaxis outweighs concerns about cardiovascular effects 1
  • Serious adverse effects from properly administered epinephrine are rare in otherwise healthy individuals 2

Special Populations

Patients on beta-blockers:

  • May have reduced response to epinephrine 4, 2
  • Have glucagon available: 20-30 μg/kg (children) or 1-5 mg (adults) for refractory hypotension 4, 2
  • Still administer epinephrine as first-line treatment 2

Patients with cardiovascular disease:

  • Epinephrine is still indicated—serious adverse effects are rare 2
  • Monitor closely but do not withhold treatment 1

Observation and Disposition

Minimum observation period:

  • All patients receiving epinephrine must be observed for 4-6 hours minimum 2

Extended observation (12 hours) required for:

  • Severe initial reactions 2
  • History of biphasic reactions 2
  • Delayed epinephrine administration 2
  • Ongoing symptoms despite treatment 2

Discharge Planning

Prescribe at discharge:

  • Two epinephrine auto-injectors with hands-on training 4, 2
  • Written anaphylaxis emergency action plan 4, 2
  • Continue adjunctive medications (antihistamines) for 2-3 days 4

Follow-up:

  • Arrange appointment with primary care physician and allergist/immunologist 4, 2
  • Provide education on allergen avoidance 4
  • Consider medical identification jewelry or wallet card 2

Mild Allergic Reactions (Without Anaphylaxis)

For localized reactions without systemic symptoms:

  • H1 antihistamines (oral diphenhydramine or cetirizine) are appropriate 1
  • Local treatment with cool compresses or topical corticosteroids 1
  • However, if any doubt exists about progression to anaphylaxis, err on the side of caution and administer epinephrine 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Second-Line Treatment for Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Customizing anaphylaxis guidelines for emergency medicine.

The Journal of emergency medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.